Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1965-12-23
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0069-0112
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
48
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
53-6
|
pubmed:dateRevised |
2008-2-20
|
pubmed:meshHeading |
pubmed-meshheading:4953646-Animals,
pubmed-meshheading:4953646-Antineoplastic Agents,
pubmed-meshheading:4953646-Dogs,
pubmed-meshheading:4953646-Female,
pubmed-meshheading:4953646-Haplorhini,
pubmed-meshheading:4953646-Hexestrol,
pubmed-meshheading:4953646-Humans,
pubmed-meshheading:4953646-Male,
pubmed-meshheading:4953646-Mice,
pubmed-meshheading:4953646-Rats
|
pubmed:year |
1965
|
pubmed:articleTitle |
Massive estrogen therapy: phase I study of hexestrol (NSC-9894).
|
pubmed:publicationType |
Journal Article
|